Amrita Daftary

Amrita Daftary, PhD, MPH
Assistant Professor 
School of Health Policy & Management
Faculty of Health
York University
Toronto, Canada
adaftary [at]



Dr. Daftary is a social and behavioural global health researcher. She has expertise in qualitative research methods, implementation science and evaluation, and health services research. Dr. Daftary examines health care seeking and caregiving practices for tuberculosis (TB) and HIV. She is well cited for her work on stigma associated with TB, including drug-resistant TB and TB-HIV coinfection. Her projects are based in a number of global settings, particularly South Africa, India, and Canada. Dr. Daftary is Director and Founder of SSHIFTB, a global virtual centre on Social Science & Health Innovations For Tuberculosis, at York University's Dahdaleh Institute of Global Health Research. She also holds adjunct appointments at the University of Toronto's Dalla Lana School of Public Health and University of KwaZulu-Natal's Centre for the AIDS Programme of Research in South Africa (CAPRISA). She is a Section Editor (social and behavioural research) at PLoS Global Public Health, and serves on the academic editorial boards for PLoS One and Scientific Reports. Dr. Daftary was nominated to the inaugural list of Canadian Women Leaders in Global Health.


  • Tuberculosis, drug-resistant TB, HIV/AIDS
  • Social determinants of health – stigma, quality of care
  • Health services research and evaluation
  • Qualitative methods, mixed methods
  • Implementation science, e-health interventions

Selected Publications:             Follow on PubMed

1.     Daftary A, Frick M, Venkatesan N, Pai M. Fighting TB stigma: we need to apply lessons learned from HIV activismBMJ Glob Health. 2017; 2:e000515

2.     Craig G, Daftary A, Engel N, O’Driscoll S. TB stigma as a social determinant of health: a systematic mapping review of research in low incidence countriesInt J Infect Dis. 2017; 56:90-100.

3.     Daftary A, Hirsch-Moverman Y, Kassie GM, Melaku Z, Gadisa T, Saito S, Howard AA. A qualitative evaluation of the acceptability of an interactive voice response system to enhance adherence to isoniazid preventive therapy in Ethiopia. AIDS Behav, 2017; 21(11):3057-67.

4.     Hirsch-Moverman Y, Daftary A, Yuengling KA, Saito S, Frederix K, Maama LB, Howard AA. Using mHealth for HIV/TB treatment support in Lesotho: Enhancing patient-provider communication in the START StudyJAIDS, 2017; 1(S1):S37-43.

5.     Daftary A, Calzavara L, Padayatchi N. The contrasting cultures of HIV and tuberculosis careAIDS, 2015; 29(1):1-4.

6.     Daftary A, Padayatchi N, O’Donnell MR. Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV coinfected patients in South AfricaGlob Public Health, 2014; 9(9):1107-16.

7.     Daftary AHIV and tuberculosis: the construction and management of double stigmaSoc Sci Med, 2012; 74(10):1512-9.


Back to top